Viewing nowCombinationTeneglib M Sustained-release Tablet 20/1000 mg
Teneligliptin Hydrochloride Hydrate 26mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.

MFDS item code 202201420 · Approved 2022.04.04 · Insurance code 643105620
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood glucose control in patients with type 2 diabetes. It is used in a combination therapy with teneligliptin and metformin, assisting in effective management of blood glucose levels alongside dietary and exercise regimens. This contributes to enhanced blood glucose control and is expected to have positive effects on diabetes management.
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose may be initiated at the patient's existing doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Because such a change may cause changes in blood glucose control, any change in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.
This medication can rarely cause a serious metabolic complication called lactic acidosis; therefore, it should not be administered to patients with impaired kidney function or liver dysfunction. The risk of hypoglycemia may increase when this medication is used with other diabetes treatments, so immediate action, such as consuming sugar, is necessary if hypoglycemia symptoms occur. This medication should not be administered to certain patient populations, such as those with moderate or severe impaired kidney function, heart failure, patients at risk for acute renal failure, type 1 diabetes patients, or pregnant women. At least 48 hours before a testing involving radiological iodine contrast materials, this medication should be stopped, and re-administered only after confirming normal kidney function afterwards. Caution should be exercised when administering this medication to patients with liver dysfunction, severe pulmonary dysfunction, serious infections, malnutrition, starvation, frailty, adrenal insufficiency, and administration can be temporarily halted if necessary. Since this medication contains tartrazine, which can cause allergic reactions, patients hypersensitive to this component should be careful. If there are persistent abdominal pain, vomiting, severe constipation, shortness of breath, fever, skin rash, or blisters during use, immediate consultation with a physician is required, as these symptoms may indicate serious side effects. Elderly patients should regularly undergo kidney function tests due to the potential for decreased renal function and should start with the minimum dosage to ensure adequate blood glucose control. It is recommended that pregnant and lactating women do not use this medication, and women who may become pregnant should confirm their pregnancy status before deciding to take the medication. In cases of overdose, immediate visit to a medical institution for appropriate treatment is necessary, as this medication can be removed by hemodialysis. Patients performing hazardous work or driving should use this medication with caution due to the risks of lactic acidosis or hypoglycemia. Additionally, this medication may interact with other drugs, so it is essential to inform the physician or pharmacist about any other medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture exposure and kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer time.
Pink oval-shaped sustained-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTeneligliptin Hydrochloride Hydrate 26mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
CombinationTeneligliptin Hydrochloride Hydrate 26mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationTeneligliptin Hydrochloride Hydrate 13mg · Metformin Hydrochloride 750mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationTeneligliptin Hydrochloride Hydrate 13mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationTeneligliptin Hydrochloride Hydrate 13mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
(Yoo) Hanpung Pharmaceutical Co., Ltd.
CombinationTeneligliptin Hydrochloride Hydrate 13mg · Metformin Hydrochloride 750mg
Tablet · Prescription medication · Combination
Hanpoong Pharmaceutical Co., Ltd.
CombinationTeneligliptin Hydrochloride Hydrate 26mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Hanpung Pharmaceutical Co., Ltd.
CombinationTeneligliptin Hydrochloride Hydrate 26mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Iyeon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.